Medicines like semaglutide have become very popular in recent years because they help people lose weight and control blood sugar.
Many people know these drugs by brand names used for diabetes and weight loss treatment.
They work by copying a natural hormone in the body called GLP-1, which helps control hunger and blood sugar levels. Because of this, doctors have mainly focused on how these drugs affect the brain and appetite.
However, scientists have long noticed something unusual. Patients taking semaglutide often show clear improvement in their liver health, even when they do not lose much weight.
This puzzled researchers for many years. It suggested that the drug might be doing more than simply helping people eat less or lose weight.
Now, a new study from Sinai Health in Toronto, published in the journal Cell Metabolism, provides an answer. The research shows that semaglutide can act directly on the liver itself. This means the drug can improve liver health in a way that is separate from weight loss.
The liver is one of the most important organs in the body. It helps process nutrients, remove toxins, and manage energy. One common liver problem is fatty liver disease, which happens when fat builds up inside liver cells. A more serious form is called MASH, where fat buildup is combined with inflammation and scarring. Over time, this can lead to liver failure.
Fatty liver disease is becoming more common, especially because of rising rates of obesity and type 2 diabetes. Doctors often advise weight loss as the main treatment. While this can help, it is not always easy for patients to achieve or maintain.
In this study, researchers wanted to understand how semaglutide improves liver health. They used advanced experiments in mice and closely studied liver cells. They discovered that semaglutide targets a small group of special liver cells. These cells are called liver sinusoidal endothelial cells, or LSECs.
These cells make up only a small part of the liver, but they play an important role. They line tiny blood vessels in the liver and help control what moves between the blood and liver tissue. They also help manage inflammation inside the liver.
The researchers found that semaglutide attaches to receptors on these cells. This was surprising because scientists previously believed liver cells did not have these receptors. Once activated, these cells begin to send signals that reduce inflammation and help the liver return to a healthier state.
Importantly, the study showed that this effect happens even when weight loss does not occur. In experiments, mice without the brain pathways for appetite still had improved liver health when given the drug. On the other hand, mice without these special liver receptors did not show improvement, even when they lost a lot of weight.
This clearly shows that semaglutide works directly on the liver, not just through weight loss.
These findings are important for patients and doctors. They suggest that the success of treatment should not only be measured by weight loss. A person’s liver health may improve even if their weight does not change much.
It also means doctors might be able to use lower doses of the drug. Lower doses may reduce side effects and lower the cost of treatment, making it more accessible.
However, there are still limits to this study. Most of the work was done in mice, so more research is needed to confirm the same effect in humans. Scientists also need to study long-term safety and the best way to use this treatment.
Overall, this study changes how we understand semaglutide. It shows that the drug has a direct effect on liver health, opening new possibilities for treating liver disease. It also reminds us that the body is complex, and medicines can work in ways we do not fully expect.
If you care about liver health, please read studies about simple habit that could give you a healthy liver, and common diabetes drug that may reverse liver inflammation.
For more information about health, please see recent studies about simple blood test that could detect your risk of fatty liver disease, and results showing this green diet may strongly lower non-alcoholic fatty liver disease.
